Tumor angiogenesis is activated when there are more proangiogenic molecules like vascular endothelial growth factor (VEGF) than antiangiogenic molecules3,4, which is one of the key factors contributing to the ESCC aggressiveness and patients’ poor prognosis5. The gene discussed is VEGFA; the disease is neoplasm.